Cargando…
T lymphocytes related biomarkers for predicting immunotherapy efficacy in non-small cell lung cancer
The immune environment is a determinant of whether patients with cancer can benefit from immunotherapy. Immune checkpoint inhibitors (ICIs) have improved the prognosis of patients with different types of malignancies and have initiated a transformation in tumor therapy. However, some patients cannot...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751340/ https://www.ncbi.nlm.nih.gov/pubmed/33376522 http://dx.doi.org/10.3892/ol.2020.12350 |